Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy

Authors

Keywords

Journal

Volume -, Issue -, Pages n/a-n/a

Publisher

Wiley

Online

2015-10-20

DOI

10.1111/jdv.13403

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started